189 related articles for article (PubMed ID: 15093697)
41. Medullary monoamines and NMDA-receptor regulation of cardiovascular responses during peripheral nociceptive stimuli.
Karlsson GA; Preuss CV; Chaitoff KA; Maher TJ; Ally A
Neurosci Res; 2006 Jul; 55(3):316-26. PubMed ID: 16684576
[TBL] [Abstract][Full Text] [Related]
42. Central hyperventilatory action of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
Le Mével JC; Lancien F; Mimassi N; Conlon JM
Gen Comp Endocrinol; 2009 Oct; 164(1):51-60. PubMed ID: 19341734
[TBL] [Abstract][Full Text] [Related]
43. Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions.
Saruta M; Takahashi K; Suzuki T; Fukuda T; Torii A; Sasano H
Peptides; 2005 Jul; 26(7):1196-206. PubMed ID: 15949638
[TBL] [Abstract][Full Text] [Related]
44. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins.
Amfilochiadis AA; Backx PH; Floras JS
J Hypertens; 2008 Jan; 26(1):61-9. PubMed ID: 18090541
[TBL] [Abstract][Full Text] [Related]
45. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
46. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
Diamant M; Kashtanov SI; Fodor M; de Wied D
Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
[TBL] [Abstract][Full Text] [Related]
47. Cocaine- and amphetamine-regulated transcript stimulates colonic motility via central CRF receptor activation and peripheral cholinergic pathways in fed, conscious rats.
Tebbe JJ; Ortmann E; Schumacher K; Mönnikes H; Kobelt P; Arnold R; Schäfer MK
Neurogastroenterol Motil; 2004 Aug; 16(4):489-96. PubMed ID: 15306004
[TBL] [Abstract][Full Text] [Related]
48. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
Aydin C; Yalcin M
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
[TBL] [Abstract][Full Text] [Related]
49. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
50. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines.
Kageyama K; Gaudriault GE; Bradbury MJ; Vale WW
Endocrinology; 2000 Jul; 141(7):2285-93. PubMed ID: 10875227
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor.
Dedeoğlu A; Fisher LA
Am J Physiol; 1994 Sep; 267(3 Pt 2):R859-64. PubMed ID: 8092332
[TBL] [Abstract][Full Text] [Related]
52. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
53. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats.
Yokotani K; Murakami Y; Okada S; Hirata M
Eur J Pharmacol; 2001 May; 419(2-3):183-9. PubMed ID: 11426840
[TBL] [Abstract][Full Text] [Related]
54. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
55. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
56. Effect of neuropeptide B on feeding behavior is influenced by endogenous corticotropin-releasing factor activities.
Aikawa S; Ishii M; Yanagisawa M; Sakakibara Y; Sakurai T
Regul Pept; 2008 Nov; 151(1-3):147-52. PubMed ID: 18760311
[TBL] [Abstract][Full Text] [Related]
57. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
[TBL] [Abstract][Full Text] [Related]
58. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats.
Iwasa T; Matsuzaki T; Kiyokawa M; Shimizu F; Minakuchi M; Kuwahara A; Maegawa M; Yasui T; Irahara M
J Neuroendocrinol; 2007 Sep; 19(9):732-8. PubMed ID: 17680889
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms.
Yalcin M; Savci V
Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713
[TBL] [Abstract][Full Text] [Related]
60. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
